Publication | Closed Access

Analysis of tumor nuclear features using artificial intelligence to predict response to neoadjuvant chemotherapy in high-risk breast cancer patients

Artificial IntelligenceBreast OncologyEngineeringMachine LearningData ScienceNeoadjuvant ChemotherapyMedicineCancer DetectionTumor Nuclear FeaturesBreast CancerAi HealthcareOncologyRadiology